JP2020502230A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502230A5
JP2020502230A5 JP2019534197A JP2019534197A JP2020502230A5 JP 2020502230 A5 JP2020502230 A5 JP 2020502230A5 JP 2019534197 A JP2019534197 A JP 2019534197A JP 2019534197 A JP2019534197 A JP 2019534197A JP 2020502230 A5 JP2020502230 A5 JP 2020502230A5
Authority
JP
Japan
Prior art keywords
methyl
pyridyl
amine
isopropyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019534197A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502230A (ja
JP7074758B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/083721 external-priority patent/WO2018115067A1/en
Publication of JP2020502230A publication Critical patent/JP2020502230A/ja
Publication of JP2020502230A5 publication Critical patent/JP2020502230A5/ja
Application granted granted Critical
Publication of JP7074758B2 publication Critical patent/JP7074758B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019534197A 2016-12-22 2017-12-20 ＰＤＥ１阻害剤としてのピラゾロ［３，４－ｂ］ピリジン及びイミダゾ［１，５－ｂ］ピリダジン Expired - Fee Related JP7074758B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201600784 2016-12-22
DKPA201600784 2016-12-22
DKPA201700404 2017-07-06
DKPA201700404 2017-07-06
PCT/EP2017/083721 WO2018115067A1 (en) 2016-12-22 2017-12-20 Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors

Publications (3)

Publication Number Publication Date
JP2020502230A JP2020502230A (ja) 2020-01-23
JP2020502230A5 true JP2020502230A5 (enExample) 2021-01-28
JP7074758B2 JP7074758B2 (ja) 2022-05-24

Family

ID=60812077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019534197A Expired - Fee Related JP7074758B2 (ja) 2016-12-22 2017-12-20 ＰＤＥ１阻害剤としてのピラゾロ［３，４－ｂ］ピリジン及びイミダゾ［１，５－ｂ］ピリダジン

Country Status (23)

Country Link
US (2) US10351561B2 (enExample)
EP (1) EP3558988B1 (enExample)
JP (1) JP7074758B2 (enExample)
KR (1) KR20190095301A (enExample)
CN (1) CN110099901B (enExample)
AU (1) AU2017384481A1 (enExample)
BR (1) BR112018017067A2 (enExample)
CA (1) CA3046588A1 (enExample)
CL (1) CL2019001669A1 (enExample)
CO (1) CO2019005538A2 (enExample)
CR (1) CR20190302A (enExample)
DO (1) DOP2019000169A (enExample)
EC (1) ECSP19043790A (enExample)
ES (1) ES2882335T3 (enExample)
IL (1) IL267561A (enExample)
JO (1) JOP20190126A1 (enExample)
MX (1) MX2019007509A (enExample)
PE (1) PE20191323A1 (enExample)
PH (1) PH12019501324A1 (enExample)
RU (1) RU2019116251A (enExample)
TW (1) TW201829405A (enExample)
WO (1) WO2018115067A1 (enExample)
ZA (1) ZA201904236B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
JOP20190126A1 (ar) 2016-12-22 2019-05-28 H Lundbeck As بيرازولو [3، 4-b] بيريدينات وإيميدازو [1، 5-b] بيريدازينات على هيئة مثبطات PDE1
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
RS62551B1 (sr) 2017-12-14 2021-12-31 H Lundbeck As Kombinovane terapije koje obuhvataju primenu 1h-pirazolo[4,3-b]piridina
TW201927784A (zh) 2017-12-20 2019-07-16 丹麥商Ｈ 朗德貝克公司 作為pde1抑制劑之大環
EP3728250A1 (en) 2017-12-20 2020-10-28 H. Lundbeck A/S PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS
US10766893B2 (en) 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
AU2020412779A1 (en) * 2019-12-23 2022-06-23 Sanford Burnham Prebys Medical Discovery Institute Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) modulators and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326379B1 (en) * 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
ES2319797T3 (es) * 2004-07-05 2009-05-12 Astellas Pharma Inc. Derivados de pirazolopiridina.
DE602005014375D1 (de) 2004-10-19 2009-06-18 Neurocrine Biosciences Inc Crf-rezeptor-antagonisten und zugehörige verfahren
JP5837278B2 (ja) 2006-12-05 2015-12-24 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規使用
SI2124944T1 (sl) 2007-03-14 2012-05-31 Ranbaxy Lab Ltd Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
WO2009067607A2 (en) * 2007-11-20 2009-05-28 Memory Pharmaceuticals Corporation Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders
EA201170773A1 (ru) * 2008-12-06 2012-01-30 Интра-Селлулар Терапиз, Инк. Органические соединения
WO2013142307A1 (en) 2012-03-19 2013-09-26 Abide Therapeutics Carbamate compounds and of making and using same
TW201533043A (zh) * 2013-04-18 2015-09-01 Lundbeck & Co As H 作爲ｌｒｒｋ２抑制劑的芳基吡咯并吡啶衍生化合物
US20160083400A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic guanidine derivative
WO2016042775A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic derivative
US20160083391A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic piperazine derivative
TW201629064A (zh) 2014-10-10 2016-08-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之三唑並吡酮
US20180044343A1 (en) 2015-03-16 2018-02-15 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative
TW201643167A (zh) * 2015-04-22 2016-12-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之咪唑並三酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
JOP20190126A1 (ar) 2016-12-22 2019-05-28 H Lundbeck As بيرازولو [3، 4-b] بيريدينات وإيميدازو [1، 5-b] بيريدازينات على هيئة مثبطات PDE1
TW201927784A (zh) 2017-12-20 2019-07-16 丹麥商Ｈ 朗德貝克公司 作為pde1抑制劑之大環
US10766893B2 (en) 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Similar Documents

Publication Publication Date Title
JP2020502230A5 (enExample)
RU2019116251A (ru) Пиразоло[3,4-b]пиридины и имидазо[1,5-b]пиридазины в качестве ингибиторов pde1
JP2016520116A5 (enExample)
JP2014513110A5 (enExample)
RU2018123779A (ru) Новые соединения
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
CA3067765A1 (en) Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
JP2016516043A5 (enExample)
JP2013522354A5 (enExample)
JP2017512786A5 (enExample)
JP2013515729A5 (enExample)
JP2011500806A5 (enExample)
JP2016537384A5 (enExample)
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
JP2011500758A5 (enExample)
JP2016526576A5 (enExample)
JP2015517566A5 (enExample)
RU2016110483A (ru) Производные пирролопиридина или пиразолопиридина
RU2015115400A (ru) Гетероароматические соединения и их применение в качестве допаминовых D1 лигантов
JP2012532931A5 (enExample)
HRP20210447T1 (hr) Piridinski spoj
SI2935248T1 (en) Compounds and procedures for kinase modulation and indications for the latter
JP2013528204A5 (enExample)
JP2014505735A5 (enExample)